ID   CTDP1_HUMAN             Reviewed;         961 AA.
AC   Q9Y5B0; A8MY97; Q7Z644; Q96BZ1; Q9Y6F5;
DT   13-APR-2004, integrated into UniProtKB/Swiss-Prot.
DT   05-APR-2011, sequence version 3.
DT   10-MAY-2017, entry version 166.
DE   RecName: Full=RNA polymerase II subunit A C-terminal domain phosphatase;
DE            EC=3.1.3.16;
DE   AltName: Full=TFIIF-associating CTD phosphatase;
GN   Name=CTDP1; Synonyms=FCP1;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RC   TISSUE=Cervix carcinoma;
RX   PubMed=10385623; DOI=10.1101/gad.13.12.1540;
RA   Cho H., Kim T.-K., Mancebo H., Lane W.S., Flores O., Reinberg D.;
RT   "A protein phosphatase functions to recycle RNA polymerase II.";
RL   Genes Dev. 13:1540-1552(1999).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16177791; DOI=10.1038/nature03983;
RA   Nusbaum C., Zody M.C., Borowsky M.L., Kamal M., Kodira C.D.,
RA   Taylor T.D., Whittaker C.A., Chang J.L., Cuomo C.A., Dewar K.,
RA   FitzGerald M.G., Yang X., Abouelleil A., Allen N.R., Anderson S.,
RA   Bloom T., Bugalter B., Butler J., Cook A., DeCaprio D., Engels R.,
RA   Garber M., Gnirke A., Hafez N., Hall J.L., Norman C.H., Itoh T.,
RA   Jaffe D.B., Kuroki Y., Lehoczky J., Lui A., Macdonald P., Mauceli E.,
RA   Mikkelsen T.S., Naylor J.W., Nicol R., Nguyen C., Noguchi H.,
RA   O'Leary S.B., Piqani B., Smith C.L., Talamas J.A., Topham K.,
RA   Totoki Y., Toyoda A., Wain H.M., Young S.K., Zeng Q., Zimmer A.R.,
RA   Fujiyama A., Hattori M., Birren B.W., Sakaki Y., Lander E.S.;
RT   "DNA sequence and analysis of human chromosome 18.";
RL   Nature 437:551-555(2005).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (DEC-2006) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 4), AND NUCLEOTIDE
RP   SEQUENCE [LARGE SCALE MRNA] OF 88-961 (ISOFORM 1).
RC   TISSUE=Colon, Lymph, and Ovary;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 106-961 (ISOFORM 1), NUCLEOTIDE SEQUENCE
RP   [MRNA] OF 106-961 (ISOFORM 4), TISSUE SPECIFICITY, AND INTERACTION
RP   WITH GTF2F1.
RC   TISSUE=Placenta;
RX   PubMed=9765293; DOI=10.1074/jbc.273.42.27593;
RA   Archambault J., Pan G., Dahmus G.K., Cartier M., Marshall N.,
RA   Zhang S., Dahmus M.E., Greenblatt J.;
RT   "FCP1, the RAP74-interacting subunit of a human protein phosphatase
RT   that dephosphorylates the carboxyl-terminal domain of RNA polymerase
RT   IIO.";
RL   J. Biol. Chem. 273:27593-27601(1998).
RN   [6]
RP   INTERACTION WITH WDR77; SNRPB AND SNRNP70.
RX   PubMed=12560496; DOI=10.1093/nar/gkg197;
RA   Licciardo P., Amente S., Ruggiero L., Monti M., Pucci P., Lania L.,
RA   Majello B.;
RT   "The FCP1 phosphatase interacts with RNA polymerase II and with MEP50
RT   a component of the methylosome complex involved in the assembly of
RT   snRNP.";
RL   Nucleic Acids Res. 31:999-1005(2003).
RN   [7]
RP   PHOSPHORYLATION.
RX   PubMed=12591939; DOI=10.1073/pnas.2628049100;
RA   Friedl E.M., Lane W.S., Erdjument-Bromage H., Tempst P., Reinberg D.;
RT   "The C-terminal domain phosphatase and transcription elongation
RT   activities of FCP1 are regulated by phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 100:2328-2333(2003).
RN   [8]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-869, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=17081983; DOI=10.1016/j.cell.2006.09.026;
RA   Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P.,
RA   Mann M.;
RT   "Global, in vivo, and site-specific phosphorylation dynamics in
RT   signaling networks.";
RL   Cell 127:635-648(2006).
RN   [9]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [10]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-780, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19608861; DOI=10.1126/science.1175371;
RA   Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M.,
RA   Walther T.C., Olsen J.V., Mann M.;
RT   "Lysine acetylation targets protein complexes and co-regulates major
RT   cellular functions.";
RL   Science 325:834-840(2009).
RN   [11]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-674; SER-869 AND
RP   SER-872, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE
RP   ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=20068231; DOI=10.1126/scisignal.2000475;
RA   Olsen J.V., Vermeulen M., Santamaria A., Kumar C., Miller M.L.,
RA   Jensen L.J., Gnad F., Cox J., Jensen T.S., Nigg E.A., Brunak S.,
RA   Mann M.;
RT   "Quantitative phosphoproteomics reveals widespread full
RT   phosphorylation site occupancy during mitosis.";
RL   Sci. Signal. 3:RA3-RA3(2010).
RN   [12]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [13]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-872, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21406692; DOI=10.1126/scisignal.2001570;
RA   Rigbolt K.T., Prokhorova T.A., Akimov V., Henningsen J.,
RA   Johansen P.T., Kratchmarova I., Kassem M., Mann M., Olsen J.V.,
RA   Blagoev B.;
RT   "System-wide temporal characterization of the proteome and
RT   phosphoproteome of human embryonic stem cell differentiation.";
RL   Sci. Signal. 4:RS3-RS3(2011).
RN   [14]
RP   FUNCTION, AND SUBCELLULAR LOCATION.
RX   PubMed=22692537; DOI=10.1038/ncomms1886;
RA   Visconti R., Palazzo L., Della Monica R., Grieco D.;
RT   "Fcp1-dependent dephosphorylation is required for M-phase-promoting
RT   factor inactivation at mitosis exit.";
RL   Nat. Commun. 3:894-894(2012).
RN   [15]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT MET-1, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=22814378; DOI=10.1073/pnas.1210303109;
RA   Van Damme P., Lasa M., Polevoda B., Gazquez C., Elosegui-Artola A.,
RA   Kim D.S., De Juan-Pardo E., Demeyer K., Hole K., Larrea E.,
RA   Timmerman E., Prieto J., Arnesen T., Sherman F., Gevaert K.,
RA   Aldabe R.;
RT   "N-terminal acetylome analyses and functional insights of the N-
RT   terminal acetyltransferase NatB.";
RL   Proc. Natl. Acad. Sci. U.S.A. 109:12449-12454(2012).
RN   [16]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-395; SER-674; SER-740
RP   AND SER-839, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE
RP   ANALYSIS].
RC   TISSUE=Cervix carcinoma, and Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [17]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D.,
RA   Wang L., Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human
RT   liver phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [18]
RP   X-RAY CRYSTALLOGRAPHY (2.0 ANGSTROMS) OF 944-961 IN COMPLEX WITH
RP   GTF2F1.
RX   PubMed=12591941; DOI=10.1073/pnas.262798199;
RA   Kamada K., Roeder R.G., Burley S.K.;
RT   "Molecular mechanism of recruitment of TFIIF-associating RNA
RT   polymerase C-terminal domain phosphatase (FCP1) by transcription
RT   factor IIF.";
RL   Proc. Natl. Acad. Sci. U.S.A. 100:2296-2299(2003).
RN   [19]
RP   INVOLVEMENT IN CCFDN.
RX   PubMed=14517542; DOI=10.1038/ng1243;
RA   Varon R., Gooding R., Steglich C., Marns L., Tang H., Angelicheva D.,
RA   Yong K.K., Ambrugger P., Reinhold A., Morar B., Baas F., Kwa M.,
RA   Tournev I., Guerguelcheva V., Kremensky I., Lochmueller H.,
RA   Muellner-Eidenboeck A., Merlini L., Neumann L., Buerger J., Walter M.,
RA   Swoboda K., Thomas P.K., von Moers A., Risch N., Kalaydjieva L.;
RT   "Partial deficiency of the C-terminal-domain phosphatase of RNA
RT   polymerase II is associated with congenital cataracts facial
RT   dysmorphism neuropathy syndrome.";
RL   Nat. Genet. 35:185-189(2003).
CC   -!- FUNCTION: Processively dephosphorylates 'Ser-2' and 'Ser-5' of the
CC       heptad repeats YSPTSPS in the C-terminal domain of the largest RNA
CC       polymerase II subunit. This promotes the activity of RNA
CC       polymerase II. Plays a role in the exit from mitosis by
CC       dephosphorylating crucial mitotic substrates (USP44, CDC20 and
CC       WEE1) that are required for M-phase-promoting factor (MPF)/CDK1
CC       inactivation. {ECO:0000269|PubMed:22692537}.
CC   -!- CATALYTIC ACTIVITY: [a protein]-serine/threonine phosphate + H(2)O
CC       = [a protein]-serine/threonine + phosphate.
CC   -!- SUBUNIT: Homodimer. Interacts with GTF2F1. Interacts with WDR77,
CC       SNRPB and SNRNP70. {ECO:0000269|PubMed:12560496,
CC       ECO:0000269|PubMed:12591941, ECO:0000269|PubMed:9765293}.
CC   -!- SUBCELLULAR LOCATION: Nucleus {ECO:0000269|PubMed:22692537}.
CC       Cytoplasm, cytoskeleton, microtubule organizing center, centrosome
CC       {ECO:0000269|PubMed:22692537}. Cytoplasm, cytoskeleton, spindle
CC       pole {ECO:0000269|PubMed:22692537}. Midbody
CC       {ECO:0000269|PubMed:22692537}. Note=Found at centrosomes in
CC       prometaphase, at spindle and spindle poles in metaphase and at
CC       spindle midzone and midbody in anaphase and telophase-G1
CC       respectively.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=Q9Y5B0-1; Sequence=Displayed;
CC       Name=4;
CC         IsoId=Q9Y5B0-4; Sequence=VSP_009865;
CC   -!- TISSUE SPECIFICITY: Ubiquitously expressed.
CC       {ECO:0000269|PubMed:9765293}.
CC   -!- PTM: Phosphorylated. In the presence of TFIIF, the phosphorylated
CC       form has an increased CTD phosphatase activity. The
CC       phosphorylation is required for the physical interaction with
CC       GTF2F1. {ECO:0000269|PubMed:12591939}.
CC   -!- DISEASE: Congenital cataracts, facial dysmorphism, and neuropathy
CC       (CCFDN) [MIM:604168]: An autosomal recessive developmental
CC       disorder characterized by a complex clinical phenotype with
CC       seemingly unrelated features involving multiple organs and
CC       systems. Developmental abnormalities include congenital cataracts
CC       and microcorneae, hypomyelination of the peripheral nervous
CC       system, impaired physical growth, delayed early motor and
CC       intellectual development, facial dysmorphism and hypogonadism.
CC       Central nervous system involvement, with cerebral and spinal cord
CC       atrophy, may be the result of disrupted development with
CC       superimposed degenerative changes. Affected individuals are prone
CC       to severe rhabdomyolysis after viral infections and to serious
CC       complications related to general anesthesia (such as pulmonary
CC       edema and epileptic seizures). {ECO:0000269|PubMed:14517542}.
CC       Note=The disease is caused by mutations affecting the gene
CC       represented in this entry.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAC64549.1; Type=Miscellaneous discrepancy; Note=Cloning artifact.; Evidence={ECO:0000305};
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AF154115; AAD42088.1; -; mRNA.
DR   EMBL; AC021594; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC068473; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471117; EAW66631.1; -; Genomic_DNA.
DR   EMBL; BC015010; AAH15010.1; -; mRNA.
DR   EMBL; BC052576; AAH52576.1; -; mRNA.
DR   EMBL; BC063447; AAH63447.1; -; mRNA.
DR   EMBL; AF081287; AAC64549.1; ALT_SEQ; mRNA.
DR   CCDS; CCDS12017.1; -. [Q9Y5B0-1]
DR   CCDS; CCDS12018.1; -. [Q9Y5B0-4]
DR   RefSeq; NP_001189433.1; NM_001202504.1.
DR   RefSeq; NP_004706.3; NM_004715.4. [Q9Y5B0-1]
DR   RefSeq; NP_430255.2; NM_048368.3. [Q9Y5B0-4]
DR   UniGene; Hs.465490; -.
DR   UniGene; Hs.734021; -.
DR   PDB; 1J2X; X-ray; 2.00 A; B=944-961.
DR   PDB; 1ONV; NMR; -; B=879-961.
DR   PDB; 2K7L; NMR; -; B=582-600.
DR   PDBsum; 1J2X; -.
DR   PDBsum; 1ONV; -.
DR   PDBsum; 2K7L; -.
DR   DisProt; DP00177; -.
DR   ProteinModelPortal; Q9Y5B0; -.
DR   SMR; Q9Y5B0; -.
DR   BioGrid; 114597; 56.
DR   DIP; DIP-41788N; -.
DR   IntAct; Q9Y5B0; 12.
DR   MINT; MINT-275991; -.
DR   STRING; 9606.ENSP00000299543; -.
DR   DEPOD; Q9Y5B0; -.
DR   iPTMnet; Q9Y5B0; -.
DR   PhosphoSitePlus; Q9Y5B0; -.
DR   BioMuta; CTDP1; -.
DR   DMDM; 327478586; -.
DR   EPD; Q9Y5B0; -.
DR   PaxDb; Q9Y5B0; -.
DR   PeptideAtlas; Q9Y5B0; -.
DR   PRIDE; Q9Y5B0; -.
DR   DNASU; 9150; -.
DR   Ensembl; ENST00000075430; ENSP00000075430; ENSG00000060069. [Q9Y5B0-4]
DR   Ensembl; ENST00000613122; ENSP00000484525; ENSG00000060069. [Q9Y5B0-1]
DR   GeneID; 9150; -.
DR   KEGG; hsa:9150; -.
DR   UCSC; uc002lnh.3; human. [Q9Y5B0-1]
DR   CTD; 9150; -.
DR   DisGeNET; 9150; -.
DR   GeneCards; CTDP1; -.
DR   GeneReviews; CTDP1; -.
DR   HGNC; HGNC:2498; CTDP1.
DR   HPA; CAB032641; -.
DR   HPA; HPA040394; -.
DR   MalaCards; CTDP1; -.
DR   MIM; 604168; phenotype.
DR   MIM; 604927; gene.
DR   neXtProt; NX_Q9Y5B0; -.
DR   OpenTargets; ENSG00000060069; -.
DR   Orphanet; 48431; Congenital cataracts - facial dysmorphism - neuropathy.
DR   PharmGKB; PA27001; -.
DR   eggNOG; KOG0323; Eukaryota.
DR   eggNOG; COG5190; LUCA.
DR   GeneTree; ENSGT00390000015641; -.
DR   HOGENOM; HOG000112039; -.
DR   HOVERGEN; HBG051213; -.
DR   InParanoid; Q9Y5B0; -.
DR   KO; K15732; -.
DR   OMA; TREHYHA; -.
DR   OrthoDB; EOG091G05JF; -.
DR   PhylomeDB; Q9Y5B0; -.
DR   TreeFam; TF315104; -.
DR   Reactome; R-HSA-112382; Formation of RNA Pol II elongation complex.
DR   Reactome; R-HSA-112387; Elongation arrest and recovery.
DR   Reactome; R-HSA-113418; Formation of the Early Elongation Complex.
DR   Reactome; R-HSA-167152; Formation of HIV elongation complex in the absence of HIV Tat.
DR   Reactome; R-HSA-167158; Formation of the HIV-1 Early Elongation Complex.
DR   Reactome; R-HSA-167200; Formation of HIV-1 elongation complex containing HIV-1 Tat.
DR   Reactome; R-HSA-167238; Pausing and recovery of Tat-mediated HIV elongation.
DR   Reactome; R-HSA-167242; Abortive elongation of HIV-1 transcript in the absence of Tat.
DR   Reactome; R-HSA-167243; Tat-mediated HIV elongation arrest and recovery.
DR   Reactome; R-HSA-167246; Tat-mediated elongation of the HIV-1 transcript.
DR   Reactome; R-HSA-167287; HIV elongation arrest and recovery.
DR   Reactome; R-HSA-167290; Pausing and recovery of HIV elongation.
DR   Reactome; R-HSA-674695; RNA Polymerase II Pre-transcription Events.
DR   Reactome; R-HSA-6796648; TP53 Regulates Transcription of DNA Repair Genes.
DR   Reactome; R-HSA-75955; RNA Polymerase II Transcription Elongation.
DR   SIGNOR; Q9Y5B0; -.
DR   ChiTaRS; CTDP1; human.
DR   EvolutionaryTrace; Q9Y5B0; -.
DR   GeneWiki; CTDP1; -.
DR   GenomeRNAi; 9150; -.
DR   PRO; PR:Q9Y5B0; -.
DR   Proteomes; UP000005640; Chromosome 18.
DR   Bgee; ENSG00000060069; -.
DR   CleanEx; HS_CTDP1; -.
DR   ExpressionAtlas; Q9Y5B0; baseline and differential.
DR   Genevisible; Q9Y5B0; HS.
DR   GO; GO:0015629; C:actin cytoskeleton; IDA:HPA.
DR   GO; GO:0005813; C:centrosome; IDA:UniProtKB.
DR   GO; GO:0005737; C:cytoplasm; IEA:UniProtKB-KW.
DR   GO; GO:0016591; C:DNA-directed RNA polymerase II, holoenzyme; IBA:GO_Central.
DR   GO; GO:0030496; C:midbody; IDA:UniProtKB.
DR   GO; GO:0016607; C:nuclear speck; IDA:HPA.
DR   GO; GO:0005654; C:nucleoplasm; TAS:Reactome.
DR   GO; GO:0005634; C:nucleus; IDA:CAFA.
DR   GO; GO:0043234; C:protein complex; IMP:CAFA.
DR   GO; GO:0005819; C:spindle; IDA:UniProtKB.
DR   GO; GO:0051233; C:spindle midzone; IDA:UniProtKB.
DR   GO; GO:0000922; C:spindle pole; IDA:UniProtKB.
DR   GO; GO:0008420; F:CTD phosphatase activity; IDA:UniProtKB.
DR   GO; GO:0004721; F:phosphoprotein phosphatase activity; TAS:Reactome.
DR   GO; GO:0030957; F:Tat protein binding; IPI:CAFA.
DR   GO; GO:0001096; F:TFIIF-class transcription factor binding; IPI:CAFA.
DR   GO; GO:0051301; P:cell division; IEA:UniProtKB-KW.
DR   GO; GO:0070940; P:dephosphorylation of RNA polymerase II C-terminal domain; IBA:GO_Central.
DR   GO; GO:0010458; P:exit from mitosis; IMP:UniProtKB.
DR   GO; GO:0061052; P:negative regulation of cell growth involved in cardiac muscle cell development; IEA:Ensembl.
DR   GO; GO:0043923; P:positive regulation by host of viral transcription; IDA:CAFA.
DR   GO; GO:0050434; P:positive regulation of viral transcription; TAS:Reactome.
DR   GO; GO:0006470; P:protein dephosphorylation; IDA:UniProtKB.
DR   GO; GO:0006368; P:transcription elongation from RNA polymerase II promoter; TAS:Reactome.
DR   GO; GO:0006366; P:transcription from RNA polymerase II promoter; TAS:Reactome.
DR   CDD; cd00027; BRCT; 1.
DR   Gene3D; 3.40.50.1000; -; 1.
DR   Gene3D; 3.40.50.10190; -; 1.
DR   InterPro; IPR001357; BRCT_dom.
DR   InterPro; IPR015388; FCP1_C.
DR   InterPro; IPR004274; FCP1_dom.
DR   InterPro; IPR011947; FCP1_euk.
DR   InterPro; IPR023214; HAD-like_dom.
DR   Pfam; PF09309; FCP1_C; 1.
DR   Pfam; PF03031; NIF; 1.
DR   SMART; SM00292; BRCT; 1.
DR   SMART; SM00577; CPDc; 1.
DR   SUPFAM; SSF52113; SSF52113; 1.
DR   SUPFAM; SSF56784; SSF56784; 1.
DR   TIGRFAMs; TIGR02250; FCP1_euk; 1.
DR   PROSITE; PS50172; BRCT; 1.
DR   PROSITE; PS50969; FCP1; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Acetylation; Alternative splicing; Cataract; Cell cycle;
KW   Cell division; Complete proteome; Cytoplasm; Cytoskeleton; Hydrolase;
KW   Mitosis; Nucleus; Phosphoprotein; Polymorphism; Protein phosphatase;
KW   Reference proteome.
FT   CHAIN         1    961       RNA polymerase II subunit A C-terminal
FT                                domain phosphatase.
FT                                /FTId=PRO_0000212564.
FT   DOMAIN      178    344       FCP1 homology. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00336}.
FT   DOMAIN      629    728       BRCT. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00033}.
FT   COMPBIAS    455    478       Ser-rich.
FT   COMPBIAS    577    582       Poly-Glu.
FT   MOD_RES       1      1       N-acetylmethionine.
FT                                {ECO:0000244|PubMed:22814378}.
FT   MOD_RES     395    395       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   MOD_RES     674    674       Phosphoserine.
FT                                {ECO:0000244|PubMed:20068231,
FT                                ECO:0000244|PubMed:23186163}.
FT   MOD_RES     740    740       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   MOD_RES     780    780       N6-acetyllysine.
FT                                {ECO:0000244|PubMed:19608861}.
FT   MOD_RES     839    839       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   MOD_RES     869    869       Phosphoserine.
FT                                {ECO:0000244|PubMed:17081983,
FT                                ECO:0000244|PubMed:20068231}.
FT   MOD_RES     872    872       Phosphoserine.
FT                                {ECO:0000244|PubMed:20068231,
FT                                ECO:0000244|PubMed:21406692}.
FT   VAR_SEQ     807    961       AVPPPQPQMFGEELPDAQDGEQPGPSRRKRQPSMSETMPLY
FT                                TLCKEDLESMDKEVDDILGEGSDDSDSEKRRPEEQEEEPQP
FT                                RKPGTRRERTLGAPASSERSAAGGRGPRGHKRKLNEEDAAS
FT                                ESSRESSNEDEGSSSEADEMAKALEAELNDLM -> WTTSL
FT                                EKAATTATARRGGLRSRRRSPSPGSQGPAGSGRSGHLRPAR
FT                                GARQGAGGPEATRGS (in isoform 4).
FT                                {ECO:0000303|PubMed:15489334,
FT                                ECO:0000303|PubMed:9765293}.
FT                                /FTId=VSP_009865.
FT   VARIANT     282    282       S -> F (in dbSNP:rs4799078).
FT                                /FTId=VAR_060440.
FT   VARIANT     340    340       T -> M (in dbSNP:rs2279103).
FT                                /FTId=VAR_018264.
FT   VARIANT     519    519       P -> H (in dbSNP:rs557503).
FT                                /FTId=VAR_060441.
FT   VARIANT     755    755       L -> S (in dbSNP:rs34967023).
FT                                /FTId=VAR_032763.
FT   CONFLICT     61     61       S -> A (in Ref. 1; AAD42088 and 4;
FT                                AAH63447). {ECO:0000305}.
FT   CONFLICT    157    157       P -> A (in Ref. 5; AAC64549).
FT                                {ECO:0000305}.
FT   CONFLICT    281    281       F -> I (in Ref. 4; AAH52576).
FT                                {ECO:0000305}.
FT   CONFLICT    305    305       E -> K (in Ref. 1; AAD42088).
FT                                {ECO:0000305}.
FT   CONFLICT    390    390       A -> P (in Ref. 5; AAC64549).
FT                                {ECO:0000305}.
FT   CONFLICT    478    478       S -> T (in Ref. 5; AAC64549).
FT                                {ECO:0000305}.
FT   CONFLICT    486    487       KP -> NA (in Ref. 5; AAC64549).
FT                                {ECO:0000305}.
FT   CONFLICT    504    505       EP -> DA (in Ref. 5; AAC64549).
FT                                {ECO:0000305}.
FT   CONFLICT    513    513       L -> V (in Ref. 5; AAC64549).
FT                                {ECO:0000305}.
FT   CONFLICT    656    657       EH -> DD (in Ref. 5; AAC64549).
FT                                {ECO:0000305}.
FT   CONFLICT    896    900       ERTLG -> GADAR (in Ref. 1; AAD42088).
FT                                {ECO:0000305}.
FT   HELIX       586    598       {ECO:0000244|PDB:2K7L}.
FT   HELIX       945    956       {ECO:0000244|PDB:1J2X}.
FT   TURN        957    959       {ECO:0000244|PDB:1J2X}.
SQ   SEQUENCE   961 AA;  104399 MW;  62B88FFD9CE4B157 CRC64;
     MEVPAAGRVP AEGAPTAAVA EVRCPGPAPL RLLEWRVAAG AAVRIGSVLA VFEAAASAQS
     SGASQSRVAS GGCVRPARPE RRLRSERAGV VRELCAQPGQ VVAPGAVLVR LEGCSHPVVM
     KGLCAECGQD LTQLQSKNGK QQVPLSTATV SMVHSVPELM VSSEQAEQLG REDQQRLHRN
     RKLVLMVDLD QTLIHTTEQH CQQMSNKGIF HFQLGRGEPM LHTRLRPHCK DFLEKIAKLY
     ELHVFTFGSR LYAHTIAGFL DPEKKLFSHR ILSRDECIDP FSKTGNLRNL FPCGDSMVCI
     IDDREDVWKF APNLITVKKY VYFQGTGDMN APPGSRESQT RKKVNHSRGT EVSEPSPPVR
     DPEGVTQAPG VEPSNGLEKP ARELNGSEAA TPRDSPRPGK PDERDIWPPA QAPTSSQELA
     GAPEPQGSCA QGGRVAPGQR PAQGATGTDL DFDLSSDSES SSESEGTKSS SSASDGESEG
     KRGRQKPKAA PEGAGALAQG SSLEPGRPAA PSLPGEAEPG AHAPDKEPEL GGQEEGERDG
     LCGLGNGCAD RKEAETESQN SELSGVTAGE SLDQSMEEEE EEDTDEDDHL IYLEEILVRV
     HTDYYAKYDR YLNKEIEEAP DIRKIVPELK SKVLADVAII FSGLHPTNFP IEKTREHYHA
     TALGAKILTR LVLSPDAPDR ATHLIAARAG TEKVLQAQEC GHLHVVNPDW LWSCLERWDK
     VEEQLFPLRD DHTKAQRENS PAAFPDREGV PPTALFHPMP VLPKAQPGPE VRIYDSNTGK
     LIRTGARGPP APSSSLPIRQ EPSSFRAVPP PQPQMFGEEL PDAQDGEQPG PSRRKRQPSM
     SETMPLYTLC KEDLESMDKE VDDILGEGSD DSDSEKRRPE EQEEEPQPRK PGTRRERTLG
     APASSERSAA GGRGPRGHKR KLNEEDAASE SSRESSNEDE GSSSEADEMA KALEAELNDL
     M
//
